NEW YORK - A group of 25 state attorneys general oppose a settlement of U.S. opioid probes being negotiated with Purdue Pharma LP and members of the wealthy Sackler family who own it, arguing the deal would improperly entangle state and local officials with future sales of the company’s addictive pain drug OxyContin.
One controversial aspect of that proposal is that the entity would steer proceeds from continued sales of OxyContin to those litigants, which include myriad state and local governments. The opposition, including by the attorneys general from Massachusetts, New York and California, could complicate complex negotiations to resolve both the Justice Department probes and thousands of lawsuits alleging Purdue and Sackler family members aggressively marketed prescription painkillers while downplaying their abuse and overdose risks, according to people familiar with the process.
The letter is signed mostly by Democratic state attorneys general. In the case of New Hampshire, it includes the signature of the deputy to that state’s Republican attorney general.Purdue, which filed for bankruptcy last year facing an onslaught of litigation, and its owners are attempting to settle widespread opioid litigation under terms that require it to also resolve Justice Department probes.
Stamford, Connecticut-based Purdue has proposed transforming into a public benefit company that it estimates will deliver more than $10 billion to plaintiffs, partly through millions of doses of lifesaving opioid addiction and overdose reversal medications the company is developing. The settlement under discussion includes a $2 billion criminal forfeiture that the Justice Department is prepared to largely waive if Purdue steers that money to communities harmed by opioids and receives bankruptcy-court approval to become a public benefit company as it envisioned.
The Sacklers belong in a Colorado Super Max 4*4 cell unit.
Where those 80's at, son?
Destroy Pharma